CALLOS ANDREW (Chief Commercial Officer) sold 1.7% of their position (886.00 shares) of CYTOKINETICS INC on the open market
Open‑market sale worth $54.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/2/2026ACC: 0001061983-26-000013
Officer· Chief Commercial Officer
Since Mar 2021
-886.00
Net shares
Net seller
$54.6K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
886.00 acquired · 1.77K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+886.00
Price / share
$37.63
Trade value
$33.34K
% of position
1.8%
3/2/2026
50.44K→51.33K
Common Stock
Direct
Shares
−886.00
Price / share
$61.62
Trade value
$54.60K
% of position
1.7%
3/2/2026
51.33K→50.44K
Total
Net shares
+0.00
Net value
-$21.26K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/2/2026 | M · Option Exercise | +886.00 | $37.63 | $33.34K | 1.8% | 50.44K | 51.33K |
| Common Stock Direct | 3/2/2026 | S · Sale | −886.00 | $61.62 | $54.60K | 1.7% | 51.33K | 50.44K |
| Total | +0.00 | -$21.26K | ||||||
Derivative Transactions1
Incentive Stock Option (Right to Buy)
Direct
Converts to
Common Stock
886.00 shares
Shares
−886.00
Strike price
37.63
Held after
0.00
Exercisable
—
3/2/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Incentive Stock Option (Right to Buy) Direct | Common Stock886.00 shares | 3/2/2026 | M · Option Exercise | −886.00 | 37.63 | — | 0.00 |